/PRNewswire/ Amgen (NASDAQ:AMGN) today presented end-of-treatment data from its Phase 2 OCEAN(a)-DOSE study of investigational olpasiran (formerly AMG 890).
Poor Self-Care Practices and Being Urban Resident Strongly Predict Chronic Complications Among Patients with Type 2 Diabetes in Eastern Ethiopia: A Hospital-Based Cross-Sectional Study
NEW ORLEANS — Providers should use evidence-based recommendations to educate people with diabetes on misconceptions surrounding net carbohydrates, artificial sweeteners and very low-carbohydrate diets, according to a speaker. Maureen Chomko, RDN, CDCES, a dietitian and diabetes care and education specialist at Neighborcare Health in Seattle, said methods for calculating net
The National Lipid Association updated its scientific statement on statin intolerance with a revised definition of statin intolerance and new guidance on how to manage patients with true or partial statin intolerance. The scientific statement, presented at the NLA Scientific Sessions and published in the Journal of Clinical Lipidology, defines statin intolerance as “one or more adverse